Pulmonary Embolism Registry From Short-Term Emergency to Long-Term Follow-Up and Surveillance | MicrobiomeTrials← Back to trialsNCT07855679
Pulmonary Embolism Registry From Short-Term Emergency to Long-Term Follow-Up and Surveillance
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-06-19Est. Completion: 2031-07
Enrollment target: 5,000 participants Locations- Ospedale Santa Maria Annunziata - Azienda USL Toscana Centro, Bagno a Ripoli, Tuscany, Italy
- Nuovo Ospedale del Mugello - Azienda USL Toscana Centro, Borgo San Lorenzo, Tuscany, Italy
- Ospedale San Giuseppe - Azienda USL Toscana Centro, Empoli, Tuscany, Italy
- Ospedale Santa Maria Nuova - Azienda USL Toscana Centro, Florence, Tuscany, Italy
- Azienda Ospedaliero-Universitaria Careggi, Florence, Tuscany, Italy
- Ospedale San Giovanni di Dio (Torregalli) - Azienda USL Toscana Centro, Florence, Tuscany, Italy
- Ospedale Santi Cosma e Damiano - Azienda USL Toscana Centro, Pescia, Tuscany, Italy
- Ospedale San Jacopo - Azienda USL Toscana Centro, Pistoia, Tuscany, Italy
- Ospedale Santo Stefano - Azienda USL Toscana Centro, Prato, Tuscany, Italy
- Ospedale Versilia - Azienda USL Toscana Nord Ovest, Lido di Camaiore, Italy
- AORN Antonio Cardarelli, Naples, Italy
- Azienda Ospedaliera di Perugia - Ospedale Santa Maria della Misericordia, Perugia, Italy
- Azienda Ospedaliero-Universitaria Pisana - Ospedale Cisanello, Pisa, Italy
- AOU Città della Salute e della Scienza di Torino - Presidio Molinette, Torino, Italy
Other microbiome trials you might be interested in
StrokeMalignancies Multiple
Title Clinical Outcomes of Stroke in MalIgnanCy (COSMIC). Aims To characterize acute ischemic stroke (AIS) and spontaneo…
Multiple LocationsEst. completion Jan 2029
Percutaneous Coronary InterventionPeripheral Endovascular Intervention
V-INTERVENTION will evaluate the effectiveness of inclisiran in preventing major cardiovascular and limb events in patie…
Alexander City, United StatesEst. completion Oct 2029
Medical University of Warsaw - Infant Jesus Teaching Hospital, Warsaw, PolandHospital Universitario Ramón y Cajal, Madrid, SpainRecurrent Multiple MyelomaRefractory Multiple Myeloma
This phase II trial compares the effect of the combination of daratumumab-hyaluronidase (daratumumab) and teclistamab to…
Coeur d'Alene, United StatesEst. completion Feb 28, 2028